secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pulmatrix, Inc. (PULM)
CIK:        0001574235
Form:       8-K
Filed at:   2021-07-27T23:59:59+00:00
Accession:  0001493152-21-017825
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulmatrix board member Mark Iwicki resigns; Anand Varadan appointed
-------------------------------------------------------------------

- Mark Iwicki resigned from board on July 23, 2021, with no disagreement over operations or policies.
- Anand Varadan appointed to board as Class III director effective July 26, 2021.
- Varadan brings commercialization expertise as CCO of Chiasma and former CCO of Karyopharm.
- Appointment aligns with Pulmatrix's expansion into non-respiratory indications using iSPERSE technology.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1574235/000149315221017825/0001493152-21-017825-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1574235/000149315221017825/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-017825

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer